We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFY icon
751
Infosys
INFY
$44.9B
$2.55M 0.01%
267,677
+5,241
+2% +$50K
CFRX
752
DELISTED
ContraFect Corporation
CFRX
$2.55M 0.01%
2,081
– –
DFIN icon
753
Donnelley Financial Solutions
DFIN
$1.2B
$2.54M 0.01%
181,200
-12,700
-7% -$203K
LPT
754
DELISTED
Liberty Property Trust
LPT
$2.54M 0.01%
60,597
+52,300
+630% +$2.26M
MYGN icon
755
Myriad Genetics
MYGN
$371M
$2.49M 0.01%
85,687
+43,087
+101% +$1.55M
DHI icon
756
D.R. Horton
DHI
$38.7B
$2.48M 0.01%
71,512
-19,200
-21% -$700K
SABR icon
757
Sabre
SABR
$916M
$2.47M 0.01%
113,962
+11,400
+11% +$276K
HRB icon
758
H&R Block
HRB
$5.53B
$2.46M 0.01%
96,900
-681,203
-88% -$18.2M
EWQ icon
759
iShares MSCI France ETF
EWQ
$344M
$2.43M 0.01%
91,567
– –
MTEM
760
DELISTED
Molecular Templates, Inc.
MTEM
$2.42M 0.01%
40,000
– –
EWA icon
761
iShares MSCI Australia ETF
EWA
$1.26B
$2.4M 0.01%
124,915
– –
RCKT icon
762
Rocket Pharmaceuticals
RCKT
$382M
$2.4M 0.01%
161,828
+33,206
+26% +$551K
PBF icon
763
PBF Energy
PBF
$9.01B
$2.38M 0.01%
72,900
-117,000
-62% -$4.72M
SLF icon
764
Sun Life Financial
SLF
$44.6B
$2.36M 0.01%
71,164
+5,200
+8% +$188K
LTC
765
LTC Properties
LTC
$2.32B
$2.34M 0.01%
56,085
-29,881
-35% -$1.31M
CRD.B icon
766
Crawford & Co Class B
CRD.B
$535M
$2.3M 0.01%
256,050
-14,500
-5% -$132K
CLGX
767
DELISTED
Corelogic, Inc.
CLGX
$2.3M 0.01%
68,900
-2,651
-4% -$108K
CSR
768
Centerspace
CSR
$955M
$2.29M 0.01%
46,580
+7,590
+19% +$405K
CLB icon
769
Core Laboratories
CLB
$530M
$2.29M 0.01%
38,292
-5,913
-13% -$510K
RGP icon
770
Resources Connection
RGP
$139M
$2.28M 0.01%
160,422
-34,300
-18% -$555K
PAYC icon
771
Paycom
PAYC
$10.3B
$2.27M 0.01%
18,500
+11,000
+147% +$1.41M
DK icon
772
Delek US
DK
$4.87B
$2.26M 0.01%
69,600
-85,700
-55% -$3.24M
PENN icon
773
PENN Entertainment
PENN
$2.37B
$2.26M 0.01%
119,900
-185,100
-61% -$4.4M
ANGI icon
774
Angi Inc
ANGI
$216M
$2.25M 0.01%
13,980
-2,724
-16% -$494K
ONCE
775
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.24M 0.01%
57,236
+19,724
+53% +$855K
29 30
31
32 33

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.